BRIEF published on 12/04/2025 at 16:01, 9 months 13 days ago Vanguard Group's Disclosure on Qualcomm Securities Securities Form 8.3 Disclosure Vanguard Group Qualcomm
BRIEF published on 12/04/2025 at 16:00, 9 months 13 days ago Vanguard Discloses Stake in American Axle & Manufacturing Takeover Code Vanguard Group Stake Disclosure Share Transactions American Axle
BRIEF published on 12/04/2025 at 15:58, 9 months 13 days ago The Vanguard Group, Inc. Discloses Interest in JTC plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure JTC Plc
BRIEF published on 12/04/2025 at 15:57, 9 months 13 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Avadel Pharmaceuticals
BRIEF published on 12/04/2025 at 15:56, 9 months 13 days ago The Vanguard Group Discloses Stake in Greencore Group plc Takeover Code Vanguard Group Stake Equity Disclosure Greencore Group
PRESS RELEASE published on 12/04/2025 at 15:56, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.82% ownership in Qualcomm Incorporated. Purchase and sale of USD 0.0001 common stock announced The Vanguard Group Stock Purchase Ownership Disclosure Stock Sale Qualcomm Incorporated
BRIEF published on 12/04/2025 at 15:55, 9 months 13 days ago The Vanguard Group Discloses Position in Bluefield Solar Income Fund Disclosure Takeover Code Vanguard Group Shareholding Bluefield Solar
PRESS RELEASE published on 12/04/2025 at 15:55, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 7.50% ownership in American Axle & Manufacturing Holdings, Inc. Form 8.3 filing on 03 Dec 2025 Form 8.3 Financial Filing Vanguard Group Ownership Disclosure American Axle
BRIEF published on 12/04/2025 at 15:53, 9 months 13 days ago The Vanguard Group Discloses Position in Spire Healthcare Group Form 8.3 Takeover Code Vanguard Group Spire Healthcare Shareholding Disclosure
PRESS RELEASE published on 12/04/2025 at 15:53, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.08% stake in JTC plc as of 03 December 2025. Details on securities holdings and transactions provided in Form 8.3 Securities Transactions Form 8.3 Vanguard Group JTC Plc
Published on 09/18/2026 at 13:30, 37 minutes ago Alset AI Provides Shareholder Update, Announces Updated Investor Presentation and Appoints Mitchell Jackman as Chief Financial Officer
Published on 09/18/2026 at 06:30, 7 hours 37 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 13 hours 12 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 13 hours 42 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/18/2026 at 13:52, 14 minutes ago New rules for green claims. Does eco-friendly also mean animal-friendly?
Published on 09/18/2026 at 13:51, 15 minutes ago Completion of the Acquisition of a Majority Stake in Jucari Global Pty Ltd
Published on 09/18/2026 at 13:50, 16 minutes ago Omio expands premium overnight travel options with Twiliner
Published on 09/18/2026 at 13:30, 36 minutes ago EQS-Adhoc: Sibanye Gold Limited: Notice to Bondholders
Published on 09/18/2026 at 13:30, 36 minutes ago EQS-Adhoc: Avemio AG: Preliminary Revenue and Earnings Figures for Fiscal Year 2025
Published on 09/17/2026 at 17:40, 20 hours 27 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 20 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 7 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
